Effectiveness of a Electroencephalogram (EEG) Biofeedback for the Treatment of ADHD
EEG
Pilot Trial of a Brain-computer Interface System Based Programme for the Treatment of ADHD
3 other identifiers
interventional
20
1 country
1
Brief Summary
The aim of this study is to investigate if electroencephalogram (EEG) biofeedback incorporating the use of video games is effective in improving inattentive symptoms in children with ADHD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2008
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 4, 2008
CompletedFirst Posted
Study publicly available on registry
December 5, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedFebruary 22, 2013
February 1, 2013
3.6 years
December 4, 2008
February 20, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reliable Change Index (RCI)on ADHD Rating Scale
week 0, 5, 10, 22
Secondary Outcomes (1)
CBCL Attention Problem Score Change
Week 5, 10, 22
Study Arms (2)
Intervention
ACTIVE COMPARATOR20 sessions of EEG biofeedback training
Control
PLACEBO COMPARATOROnly 1 session of EEG biofeedback training
Interventions
Newly-developed video games employing neurofeedback strategy to be played twice a week, 1 hour per session for a period of ten weeks.
Eligibility Criteria
You may qualify if:
- Satisfy DSM-IV-TR criteria for ADHD (Combined OR Inattentive subtype)
You may not qualify if:
- Present or history of medical treatment with stimulant medication and/or Atomoxetine
- Co-morbid severe psychiatric condition or known sensori-neural deficit, e.g. complete blindness or deafness
- History of epileptic seizures
- Known mental retardation (i.e. IQ 70 and below)
- Predominantly hyperactive/impulsive subtype of ADHD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Healthcare Group, Singaporelead
- Institute for Infocomm Researchcollaborator
- Duke-NUS Graduate Medical Schoolcollaborator
Study Sites (1)
Institute of Mental Health/Woodbridge Hospital
Singapore, Singapore, 539747, Singapore
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel SS Fung
Institute of Mental Health, Singapore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant
Study Record Dates
First Submitted
December 4, 2008
First Posted
December 5, 2008
Study Start
May 1, 2008
Primary Completion
December 1, 2011
Study Completion
June 1, 2012
Last Updated
February 22, 2013
Record last verified: 2013-02